Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Madison, Wisconsin 53792


- To determine if docetaxel and cisplatin can be administered in a dose intense manner in the adjuvant setting in resected non-small cell lung cancer - To evaluate the time to progression and overall survival - To evaluate toxicities of this chemotherapy combination in the adjuvant setting - To correlate XPD and ERCC1 polymorphisms with time to progression and toxicities in patients treated with this regimen


Inclusion Criteria: - Stage IB to IIIA non-small cell lung cancer completely resected within 4 to 8 weeks of initiating treatment on study - Performance Status ECOG 0 or 1 - Peripheral neuropathy: < grade 1 - Adequate blood cell counts - Adequate liver and hepatic function - Women of childbearing potential must have a negative pregnancy test. - Men and women of childbearing potential must be willing to consent to using effective contraception while on treatment and for at least 3 months thereafter Exclusion Criteria: - Patients with a history of severe hypersensitivity reaction to Docetaxel® or other drugs formulated with polysorbate 80. - Women who are breast-feeding. - Coexistent second malignancy or history of prior malignancy within previous 5 years (excluding basal or squamous cell carcinoma of the skin that has been treated curatively) - Uncontrolled cardiac disease or uncontrolled hypertension



Primary Contact:

Principal Investigator
Anne Traynor, MD
University of Wisconsin, Madison

Backup Contact:


Location Contact:

Madison, Wisconsin 53792
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.